在肺癌患者中确定严重CIP的风险因素和生物标志物 - - 一个回顾性案例系列研究研究
Guixian Wu1,2, Jingjing Qu1, Jing Zheng1
1Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Immunotherapy
|November 26, 2024
概括
肺癌患者的严重免疫检查点抑制剂相关肺炎 (CIP) 与强迫生命能力 (FVC) 的降低有关. 在ICI治疗期间,监测FVC对于识别患有严重CIP高风险的患者至关重要.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 提供了革命性的癌症治疗方法,但可以导致严重的免疫相关不良事件,如免疫检查点抑制剂相关肺炎 (CIP).
- 严重的CIP (3-4级) 与预后不佳有关,需要对其风险因素和预测生物标志物的研究.
- 这项研究的重点是确定ICI治疗的肺癌患者中严重CIP的预测因素.
研究的目的:
- 调查与严重 (3-4级) 免疫检查点抑制剂相关肺炎 (CIP) 相关的风险因素和生物标志物.
- 在接受免疫检查点抑制剂 (ICI) 治疗的肺癌患者中确定严重CIP的预测因素.
主要方法:
- 对106名在2019年至2023年期间被诊断患有CIP的肺癌患者进行了回顾性分析.
- 患者被分为四个严重程度的CIP.
- 使用统计分析,包括单变量和多变量分析,以确定预测因素.
主要成果:
- 到CIP发病的中位时间为5.17个月.
- 3-4级CIP患者的中位数无进展生存期 (PFS) 为6.5个月,总生存期 (OS) 为11.2个月.
- 单变量分析表明脂蛋白激酶,强迫生命能力 (FVC) 和身体质量指数 (BMI) 是 3-4 级 CIP 的潜在预测因素. 多变量分析证实,FVC降低是一个显著的预测因素.
结论:
- 强迫性生命能力 (FVC) 降低至1.96以下是严重 (3-4级) 免疫检查点抑制剂相关肺炎 (CIP) 的重要预测因素.
- 对于接受免疫检查点抑制剂 (ICI) 的肺癌患者,建议对FVC进行密切监测,以预测和管理严重的CIP.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Pneumonia I: Introduction
211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Pneumonia III: Complications and Assessment
168
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
168


